Portfolio (Quarterly)
Guide ↗
Bellevue Group AG
· CIK 0001674546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 2,320,867.0 | $91.0M | 2.17% | NEW | — | $39.20 | +7.8% |
| 2 | PCVX | VAXCYTE INC | Healthcare | 1,190,697.0 | $69.2M | 1.65% | NEW | — | $58.11 | -18.4% |
| 3 | — | DAMORA THERAPEUTICS INC | — | 2,298,000.0 | $59.5M | 1.42% | NEW | — | $25.90 | — |
| 4 | — | DISC MEDICINE INC | — | 459,314.0 | $29.4M | 0.70% | NEW | — | $63.94 | — |
| 5 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 507,008.0 | $24.9M | 0.59% | NEW | — | $49.05 | +19.7% |
| 6 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 1,250,000.0 | $20.6M | 0.49% | NEW | — | $16.45 | +14.8% |
| 7 | LIVN | LIVANOVA PLC | Healthcare | 186,185.0 | $11.8M | 0.28% | NEW | — | $63.56 | +15.9% |
| 8 | RNA | ATRIUM THERAPEUTICS INC | Healthcare | 263,096.0 | $3.5M | 0.08% | NEW | — | $13.37 | -4.9% |
| 9 | EQNR | EQUINOR ASA | Energy | 17,573.0 | $742K | 0.02% | NEW | — | $42.20 | -8.4% |
| 10 | XOM | EXXON MOBIL CORP | Energy | 4,370.0 | $741K | 0.02% | NEW | — | $169.66 | -7.9% |
| 11 | BP | BP PLC | Energy | 15,644.0 | $735K | 0.02% | NEW | — | $47.00 | -4.5% |
| 12 | SHEL | SHELL PLC | Energy | 7,844.0 | $729K | 0.02% | NEW | — | $93.00 | -6.8% |
| 13 | — | PRAXIS PRECISION MEDICINES I | — | 1,757.0 | $566K | 0.01% | NEW | — | $322.19 | — |
| 14 | AGMB | AGOMAB THERAPEUTICS NV | Healthcare | 50,000.0 | $524K | 0.01% | NEW | — | $10.49 | +4.3% |
| 15 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 9,030.0 | $359K | 0.01% | NEW | — | $39.72 | +0.2% |
| 16 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 3,857.0 | $249K | 0.01% | NEW | — | $64.63 | +6.0% |
| 17 | ABVX | ABIVAX SA | Healthcare | 1,048.0 | $117K | 0.00% | NEW | — | $111.35 | +11.4% |
| 18 | — | BRIDGEBIO ONCOLOGY THERAPEUT | — | 6,982.0 | $62K | 0.00% | NEW | — | $8.95 | — |
| 19 | — | QIAGEN NV | — | 243.0 | $10K | — | NEW | — | $40.04 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.2%
Energy
0.1%
Financial Services
0.1%
Consumer Cyclical
0.0%
Communication Services
0.0%
Consumer Defensive
0.0%